Effects of Chinese medicine Tongxinluo on hyperglycemia and beta-cell damage in streptozotocin-induced diabetic rats

Chinese Medical Journal

Volumn 125, Issue 20, 2012, Pages 3675-3680

  Wang, Huai qing ^a,b   Zou, Jun jie ^c   Zhou, Xiang hai ^a   Ji, Li nong ^a   Liu, Zhi min ^c  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b CHINA THREE GORGES UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidants; Beta cell function; Diabetes; Oxidative stress; Streptozotocin; Tongxinluo

Indexed keywords

CHINESE DRUG; GLUTATHIONE; MALONALDEHYDE; MELATONIN; TONGXINLUO; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DAMAGE; CONTROLLED STUDY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOFLUORESCENCE TEST; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS; PANCREAS ISLET BETA CELL; RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DRUGS, CHINESE HERBAL; FLUORESCENT ANTIBODY TECHNIQUE; HYPERGLYCEMIA; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 84867908663     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.20.014     Document Type: Article

References (36)

1. Lenzen S. Oxidative stress: the vulnerable β-cell. Biochem Soc Trans 2008; 36: 343-347.
2. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24: 816-823.
3. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54: 1615-1625.
4. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancrease. Physiol Res 2001; 50: 537-546.
5. Liu WH, Hei ZQ, Nie H, Tang FT, Huang HQ, Li XJ, et al. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin Med J 2008; 121: 706-712.
6. Liang JQ, Wu K, Jia ZH, Liu C, Ding J, Huang SN, et al. Chinese medicine Tongxinluo modulates vascular endothelial function by inducing eNOS expression via the PI-3K/Akt/ HIF-dependent signaling pathway. J Ethnopharmacol 2011; 133: 517-523.
7. Cheng YT, Yang YJ, Zhang HT, Qian HY, Zhao JL, Meng XM, et al. Pretreatment with Tongxinluo protects porcine myocardium from ischaemia/reperfusion injury through a nitric oxide related mechanism. Chin Med J 2009; 122: 1529-1538.
8. Chen WQ, Zhong L, Zhang L, Ji XP, Zhao YX, Zhang C, et al. Chinese medicine Tongxinluo significantly lowers lipid levels and stabilizes vulnerable plaques in a rabbit model. J Ethnopharmacol 2009; 124: 103-110.
9. Karalliedde LD, Kappagoda CT. The challenge of traditional Chinese medicines for allopathic practitioners. Am J Physiol Heart Circ Physiol 2009; 397: H1967-H1969.
10. Su J, Zhang P, Zhang JJ, Qi XM, Wu YG, Shen JJ. Effects of total glycosides of paeony on oxidative stress in the kidney from diabetic rats. Phytomedicine 2010; 17: 254-260.
11. Abdelgabar AM, Bhowmick BK. The return of the leech. Int J Clin Pract 2003; 57: 103-105.
12. Lee DC, Lau AC. Effects of Panax ginseng on tumor necrosis factor-α-mediated inflammation: a mini-review. Molecules 2011; 16: 2802-2816.
13. Zhang CY, Zou JJ, Shi YQ, Qu W, Sun LL, Liu ZM. Effect of tongluo recipe on oxidative stress in kidneys of diabetic rats. Acad J Sec Mil Med Univ (Chin) 2008; 29: 940-943.
14. Zhang DG, Zhao Y, Xia PJ, Huang XQ, Liu ZM, Zhou H. Effects of Tongluo Recipe on experimental diabetic peripheral neuropathy in rats. J Chin Integr Med (Chin) 2006; 4: 601-605.
15. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species. J Pineal Res 2007; 42: 28-42.
16. Reiter RJ, Tan DX, Terron MP, Flores LJ, Czarnocki Z. Melatonin and its metabolites;new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 2007; 54: 1-9.
17. Montilla P, Vargas J, Túnez IF, Muñoz de Aqueda MC, Valdelvira ME, et al. Oxidative stress in diabetic rats induced by streptozotocin: protective effects of melatonin. J Pineal Res 1998; 25: 94-100.
18. Yavuz O, Cam M, Bukan N, Guven A, Silan F. Protective effect of melatonin on β-cell damage in streptozotocin induced diabetes in rats. Acta Histochem 2003; 105: 261-266.
19. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86: 271-278.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
21. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974; 11: 151-169.
22. Gale EA, Bingley PG, Emmett CL, Collier T. European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. European Nicotinamide Diabetes Intervention Trial (ENDIT): A randomized controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004; 363: 925-931.
23. Song YQ, Cook NR, Albert CM, Van Denburgh M, Manson JE. Effects of vitamins C and E and β-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial. Am J Clin Nutr 2009; 90: 429-437.
24. Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
25. DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 2006; 368: 1096-1105.
26. Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signaling. Cardiovasc Res 2009; 82: 9-20.
27. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension. Diabetes Care 2008; 31(Suppl 2): S170-S180.
28. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 2003; 26: 1589-1596.
29. Wang HQ, Zou JJ, Su ML, Lei YX, Zhou XL, Zhao Y, et al. Protective effects of Tongluo recipe on damaged beta-cells of rats with streptozotocin-induced diabetes. Chin J Diabetes (Chin) 2009; 17: 178-180.
30. Rausch WD, Liu S, Gille G, Radad K. Neuroprotective effects of ginsenosides. Acta Neurobiol Exp 2006; 66: 369-375.
31. Steinkamp-Fenske K, Bollinger L, Xu H, Yao Y, Horke S, Forstermann U, et al. Reciprocal regulation of endothelial nitric-oxide synthase and NADPH oxidase by betulinic acid in human endothelial cells. J Pharmacol Exp Ther 2007; 322: 836-842.
32. Chen G, Huo Y, Tan DX, Liang Z, Zhang W, Zhang Y. Melatonin in Chinese medicinal herbs. Life Sci 2003; 73: 19-26.
33. Benot S, Molinero P, Soutto M, Goberna R, Guerrero JM. Circadian variations in the rat serum total antioxidant status: correlation with melatonin levels. J Pineal Res 1998; 25: 1-4.
34. Zhang HT, Jia ZH, Zhang J, Ye ZK, Yang WX, Tian YQ, et al. No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT Trial). Chin Med J 2010; 123: 2858-2864.
35. Enghofer M, Usadel KH, Beck O, Kusterer K. Superoxide dismutase reduces islet microvascular injury induced by streptozotocin in the rat. Am J Physiol 1997; 273: E376-E382.
36. Zeng XC, Wang SX, Li WX. Identification of BmKAPi, a novel type of scorpion venom peptide with peculiar disulfide bridge pattern from Buthus martensii Karsch. Toxicon 2002; 40: 1719-1722.